Jeffrey L. Elliott - Publications

Affiliations: 
University of Texas Southwestern Medical Center, Dallas, TX, United States 

38 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2016 Dubey D, Khemani P, Remster E, Elliott JL. Gradually Progressive Spastic Ataxia in a Young Man: Steadily Unsteady. Jama Neurology. PMID 27942721 DOI: 10.1001/jamaneurol.2016.1581  0.363
2016 Williams JR, Trias E, Beilby PR, Lopez NI, Labut EM, Samuel Bradford C, Roberts BR, McAllum EJ, Crouch PJ, Rhoads TW, Pereira C, Son M, Elliott JL, Franco MC, Estévez AG, et al. Copper delivery to the CNS by CuATSM effectively treats motor neuron disease in SOD(G93A) mice co-expressing the copper-chaperone-for-SOD. Neurobiology of Disease. PMID 26826269 DOI: 10.1016/J.Nbd.2016.01.020  0.436
2014 Son M, Elliott JL. Mitochondrial defects in transgenic mice expressing Cu,Zn superoxide dismutase mutations: the role of copper chaperone for SOD1. Journal of the Neurological Sciences. 336: 1-7. PMID 24269091 DOI: 10.1016/j.jns.2013.11.004  0.342
2011 Son M, Srikanth U, Puttaparthi K, Luther C, Elliott JL. Biochemical properties and in vivo effects of the SOD1 zinc-binding site mutant (H80G). Journal of Neurochemistry. 118: 891-901. PMID 21692800 DOI: 10.1111/j.1471-4159.2011.07360.x  0.395
2011 Sadeghian H, O'Suilleabhain PE, Battiste J, Elliott JL, Trivedi JR. Huntington chorea presenting with motor neuron disease. Archives of Neurology. 68: 650-2. PMID 21555641 DOI: 10.1001/Archneurol.2011.76  0.415
2010 Stallings NR, Puttaparthi K, Luther CM, Burns DK, Elliott JL. Progressive motor weakness in transgenic mice expressing human TDP-43. Neurobiology of Disease. 40: 404-14. PMID 20621187 DOI: 10.1016/J.Nbd.2010.06.017  0.455
2009 Williams AH, Valdez G, Moresi V, Qi X, McAnally J, Elliott JL, Bassel-Duby R, Sanes JR, Olson EN. MicroRNA-206 delays ALS progression and promotes regeneration of neuromuscular synapses in mice. Science (New York, N.Y.). 326: 1549-54. PMID 20007902 DOI: 10.1126/Science.1181046  0.36
2009 Son M, Fu Q, Puttaparthi K, Matthews CM, Elliott JL. Redox susceptibility of SOD1 mutants is associated with the differential response to CCS over-expression in vivo. Neurobiology of Disease. 34: 155-62. PMID 19320055 DOI: 10.1016/j.nbd.2009.01.005  0.385
2008 Proescher JB, Son M, Elliott JL, Culotta VC. Biological effects of CCS in the absence of SOD1 enzyme activation: implications for disease in a mouse model for ALS. Human Molecular Genetics. 17: 1728-37. PMID 18337307 DOI: 10.1093/Hmg/Ddn063  0.378
2008 Son M, Leary SC, Romain N, Pierrel F, Winge DR, Haller RG, Elliott JL. Isolated cytochrome c oxidase deficiency in G93A SOD1 mice overexpressing CCS protein. The Journal of Biological Chemistry. 283: 12267-75. PMID 18334481 DOI: 10.1074/Jbc.M708523200  0.335
2007 Puttaparthi K, Van Kaer L, Elliott JL. Assessing the role of immuno-proteasomes in a mouse model of familial ALS. Experimental Neurology. 206: 53-8. PMID 17482163 DOI: 10.1016/j.expneurol.2007.03.024  0.382
2007 Son M, Puttaparthi K, Kawamata H, Rajendran B, Boyer PJ, Manfredi G, Elliott JL. Overexpression of CCS in G93A-SOD1 mice leads to accelerated neurological deficits with severe mitochondrial pathology. Proceedings of the National Academy of Sciences of the United States of America. 104: 6072-7. PMID 17389365 DOI: 10.1073/Pnas.0610923104  0.371
2006 Krishnan U, Son M, Rajendran B, Elliott JL. Novel mutations that enhance or repress the aggregation potential of SOD1. Molecular and Cellular Biochemistry. 287: 201-11. PMID 16583143 DOI: 10.1007/s11010-005-9112-4  0.31
2005 Puttaparthi K, Elliott JL. Non-neuronal induction of immunoproteasome subunits in an ALS model: possible mediation by cytokines. Experimental Neurology. 196: 441-51. PMID 16242125 DOI: 10.1016/j.expneurol.2005.08.027  0.388
2003 Puttaparthi K, Wojcik C, Rajendran B, DeMartino GN, Elliott JL. Aggregate formation in the spinal cord of mutant SOD1 transgenic mice is reversible and mediated by proteasomes. Journal of Neurochemistry. 87: 851-60. PMID 14622116 DOI: 10.1046/j.1471-4159.2003.02028.x  0.355
2003 Son M, Cloyd CD, Rothstein JD, Rajendran B, Elliott JL. Aggregate formation in Cu,Zn superoxide dismutase-related proteins. The Journal of Biological Chemistry. 278: 14331-6. PMID 12551935 DOI: 10.1074/jbc.M211698200  0.362
2002 Puttaparthi K, Gitomer WL, Krishnan U, Son M, Rajendran B, Elliott JL. Disease progression in a transgenic model of familial amyotrophic lateral sclerosis is dependent on both neuronal and non-neuronal zinc binding proteins. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 22: 8790-6. PMID 12388585 DOI: 10.1523/Jneurosci.22-20-08790.2002  0.479
2001 Elliott JL. Cytokine upregulation in a murine model of familial amyotrophic lateral sclerosis. Brain Research. Molecular Brain Research. 95: 172-8. PMID 11687290 DOI: 10.1016/S0169-328X(01)00242-X  0.452
2001 Elliott JL. Zinc and copper in the pathogenesis of amyotrophic lateral sclerosis. Progress in Neuro-Psychopharmacology & Biological Psychiatry. 25: 1169-85. PMID 11474839 DOI: 10.1016/S0278-5846(01)00185-3  0.367
2000 Honig LS, Chambliss DD, Bigio EH, Carroll SL, Elliott JL. Glutamate transporter EAAT2 splice variants occur not only in ALS, but also in AD and controls. Neurology. 55: 1082-8. PMID 11071482 DOI: 10.1212/Wnl.55.8.1082  0.354
2000 Gong YH, Elliott JL. Metallothionein expression is altered in a transgenic murine model of familial amyotrophic lateral sclerosis. Experimental Neurology. 162: 27-36. PMID 10716886 DOI: 10.1006/exnr.2000.7323  0.498
2000 Gong YH, Parsadanian AS, Andreeva A, Snider WD, Elliott JL. Restricted expression of G86R Cu/Zn superoxide dismutase in astrocytes results in astrocytosis but does not cause motoneuron degeneration. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 20: 660-5. PMID 10632595 DOI: 10.1523/Jneurosci.20-02-00660.2000  0.717
1999 Elliott JL. Experimental models of amyotrophic lateral sclerosis. Neurobiology of Disease. 6: 310-20. PMID 10527800 DOI: 10.1006/nbdi.1999.0266  0.416
1999 Katz JS, Wolfe GI, Andersson PB, Saperstein DS, Elliott JL, Nations SP, Bryan WW, Barohn RJ. Brachial amyotrophic diplegia: a slowly progressive motor neuron disorder. Neurology. 53: 1071-6. PMID 10496268 DOI: 10.1212/WNL.53.5.1071  0.435
1999 Nevo Y, Al-Lozi M, Parsadanian AS, Elliott JL, Connolly AM, Pestronk A. Mutation analysis in Emery-Dreifuss muscular dystrophy. Pediatric Neurology. 21: 456-9. PMID 10428430 DOI: 10.1016/S0887-8994(99)00023-5  0.637
1998 Elliott JL. A clearer view of upper motor neuron dysfunction in amyotrophic lateral sclerosis. Archives of Neurology. 55: 910-2. PMID 9678307 DOI: 10.1001/archneur.55.7.910  0.448
1997 Elliott JL, Kwon JM, Goodfellow PJ, Yee WC. Hereditary motor and sensory neuropathy IIB: clinical and electrodiagnostic characteristics. Neurology. 48: 23-8. PMID 9008488 DOI: 10.1212/Wnl.48.1.23  0.355
1996 Elliott JL, Snider WD. Motor neuron growth factors. Neurology. 47: S47-53. PMID 8858051 DOI: 10.1212/Wnl.47.4_Suppl_2.47S  0.641
1996 Deckwerth TL, Elliott JL, Knudson CM, Johnson EM, Snider WD, Korsmeyer SJ. BAX is required for neuronal death after trophic factor deprivation and during development. Neuron. 17: 401-11. PMID 8816704 DOI: 10.1016/S0896-6273(00)80173-7  0.63
1996 Reaume AG, Elliott JL, Hoffman EK, Kowall NW, Ferrante RJ, Siwek DF, Wilcox HM, Flood DG, Beal MF, Brown RH, Scott RW, Snider WD. Motor neurons in Cu/Zn superoxide dismutase-deficient mice develop normally but exhibit enhanced cell death after axonal injury. Nature Genetics. 13: 43-7. PMID 8673102 DOI: 10.1038/Ng0596-43  0.642
1995 Elliott JL, Snider WD. Parvalbumin is a marker of ALS-resistant motor neurons. Neuroreport. 6: 449-52. PMID 7766841 DOI: 10.1097/00001756-199502000-00011  0.622
1994 Sanner C, Elliott JL, Snider WD. Upregulation of NMDARI mRNA induced by MK-801 is associated with massive death of axotomized motor neurones in adult rats. Neurobiology of Disease. 1: 121-9. PMID 9173991 DOI: 10.1006/nbdi.1994.0015  0.63
1994 Elliott JL, Pestronk A. Progression of multifocal motor neuropathy during apparently successful treatment with human immunoglobulin. Neurology. 44: 967-8. PMID 8190308 DOI: 10.1212/Wnl.44.5.967  0.325
1994 Pestronk A, Lopate G, Kornberg AJ, Elliott JL, Blume G, Yee WC, Goodnough LT. Distal lower motor neuron syndrome with high-titer serum IgM anti-GM1 antibodies: improvement following immunotherapy with monthly plasma exchange and intravenous cyclophosphamide. Neurology. 44: 2027-31. PMID 7969954 DOI: 10.1212/WNL.44.11.2028  0.328
1993 Yan Q, Elliott JL, Matheson C, Sun J, Zhang L, Mu X, Rex KL, Snider WD. Influences of neurotrophins on mammalian motoneurons in vivo. Journal of Neurobiology. 24: 1555-77. PMID 8301265 DOI: 10.1002/neu.480241202  0.594
1992 Ruit KG, Elliott JL, Osborne PA, Yan Q, Snider WD. Selective dependence of mammalian dorsal root ganglion neurons on nerve growth factor during embryonic development. Neuron. 8: 573-87. PMID 1550679 DOI: 10.1016/0896-6273(92)90284-K  0.599
1992 Snider WD, Elliott JL, Yan Q. Axotomy-induced neuronal death during development. Journal of Neurobiology. 23: 1231-46. PMID 1469386 DOI: 10.1002/neu.480230913  0.586
1992 Yan Q, Elliott J, Snider WD. Brain-derived neurotrophic factor rescues spinal motor neurons from axotomy-induced cell death. Nature. 360: 753-5. PMID 1281520 DOI: 10.1038/360753a0  0.641
Show low-probability matches.